Ultimovacs
Menu
Close
✕
About
About Ultimovacs
Team
Board of directors
Technology
Technology overview
Immunotherapy
Clinical Studies
Phase II trials
Phase I trials
Partnering
Expanded access
Investors
Shares
Financial reports
Presentations and publications
Investor relations contacts
Analyst coverage
Governance
ESG
News
Contact
Ultimovacs
–
News
–
Ultimovacs hits the front page in Finansavisen 14.10.2021
Ultimovacs hits the front page in Finansavisen 14.10.2021
